🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Austrian Registry on Transjugular Intrahepatic Portosystemic Shunts

Recruitingn/aAges 18 Years - 99 YearsAllThomas Reiberger
NCT03409263 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Patients with TIPS will be recruited in this prospective registry study. The clinical course will be documented and biomarkers for prediction of complicatiosn will be assessed.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age 18-99 years * Portal hypertension * Anticipated or past implantation of a transjugular intrahepatic portosystemic shunt (TIPS) * Informed consent Exclusion Criteria: * Retraction of consent
💊

What it tests

  • Observational study
📍

Where

1 site
Medical University of Vienna
Vienna, Austria
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy